Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.5.2022Zentiva, k.s. (ZNT-1)5333AEzen 10 mg (tbl 90x10 mg (blis.PVC/Aclar/PVC/Al))31.5.2022Z
 23.5.2022Zentiva, k.s. (ZNT-1)6448ATezeo HCT 80 mg/12,5 mg (tbl 90x80 mg/12,5 mg (blis.OPA/Al/PVC/Al))23.5.2022R
 20.5.2022Sandoz GmbH (SAN-A)4575CRiximyo 100 mg infúzny koncentrát (con inf 2x10 ml/100 mg (liek.inj.skl.))20.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)14609SANVAL 10 mg (tbl flm 10x10 mg (blis.Al/PVC))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)18614Amoksiklav 625 mg (tbl flm 21x625 mg (blis.Al/Al))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2121DDipperam HCT 5 mg/160 mg/12,5 mg filmom obalené tablety (tbl flm 28x5 mg/160 mg/12,5 mg (blis.PVC/PVDC/Al))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)25993Ketonal 100 mg/2 ml (sol inj 5x2 ml/100 mg (amp.z jantár.skla))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28911Ospamox 500 mg filmom obalené tablety (tbl flm 14x500 mg (blis.PVC/PVDC/Al))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28913Ospamox 1000 mg filmom obalené tablety (tbl flm 14x1000 mg (blis.PVC/PVDC/Al))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)33219Amoksiklav 2x457 mg/5 ml (plu por 1x70 ml (fľ.skl.jantárová+(PP/PE)uzáver so závit.+(PP/PE)odmer.striek.))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)9181BAmlodipín/Valsartan Sandoz 5 mg/80 mg (tbl flm 28x5 mg/80 mg (blis.PVC/PVDC))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)96416Amoksiklav 312,5 mg/5 ml (plu por 1x100 ml (fľ.skl.hnedá+(PP/PE)uzáver so závit.+(PP/PE)odmer.striek.))22.5.2022R
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)08811Tianeptin Sandoz 12,5 mg filmom obalené tablety (tbl flm 90x12,5 mg (blis.PVC/PVDC/Al))20.5.2022O
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)43791Pantoprazol Sandoz 20 mg gastrorezistentné tablety (tbl ent 28x20 mg (blis.Al/OPA/Al/PVC))20.5.2022O
 20.5.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)4651DAzacitidine Sandoz 25 mg/ml prášok na injekčnú suspenziu (plv inu 1x100 mg (liek.inj.skl.))20.5.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)